OCS-01 in Treating Inflammation and Pain in Post-cataract Patients

NCT04130802 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation Corneal
Pain, Postoperative

Interventions

DRUG: OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL
DRUG: Placebo

Sponsor

Oculis